Target intelligence / Profile preview

Natural killer group 2 member D ligands and DNAX accessory molecule 1 ligands (NKG2DLs and DNAM-1Ls)

Target
NKG2DLs and DNAM-1Ls
Molecular classification
Cell surface protein, MHC class I-related protein, Immunoglobulin superfamily, Glycoprotein
01

Overview

Natural killer group 2 member D (NKG2D) ligands and DNAX accessory molecule 1 (DNAM-1) ligands are a collection of stress-induced cell surface proteins that serve as critical recognition signals for the innate and adaptive immune systems (PMID: 29463950). In humans, NKG2D ligands include MICA, MICB, and the ULBP family (ULBP1-6), while DNAM-1 ligands include CD155 (PVR) and CD112 (Nectin-2) (PMID: 31110339). These ligands are typically absent or expressed at low levels on healthy cells but are significantly upregulated on tumor cells in response to DNA damage, oncogenic transformation, or viral infection (PMID: 28615449). When these ligands bind to their respective activating receptors on natural killer (NK) cells and CD8+ T cells, they trigger potent cytotoxic activity and cytokine production to eliminate the aberrant cells (PMID: 12620224). However, tumors frequently employ evasion strategies such as proteolytic shedding of these ligands to create soluble decoys or upregulating inhibitory receptors like TIGIT to outcompete activating signals (PMID: 12193639, PMID: 19946306). Therapeutic interventions targeting this axis include NKG2D-based CAR-T cells, antibodies designed to prevent ligand shedding, and bispecific molecules that engage these ligands to redirect immune effector cells against the tumor (PMID: 29593067).

Other names
Stress-induced ligandsMICA/BULBPsPVRCD155Nectin-2CD112MIC ligandsUL16-binding proteins
02

Mechanism of action

Activation of NKG2D and DNAM-1 (CD226) receptors on NK cells and cytotoxic T cells to promote tumor cell lysis and cytokine production (PMID: 28615449).

03

Biological functions

Immune responseNK cell activationT cell costimulationImmune surveillanceCell stress response
04

Disease associations

CancerViral infectionAutoimmune disease
05

Safety considerations

On-target off-tumor toxicity due to low-level expression on healthy tissuesLigand shedding acting as an immune decoyImmune evasion via TIGIT competitionCytokine release syndrome associated with CAR-T therapies
06

Interacting drugs

CYAD-01

5 more in the full profile.

07

Biomarkers

MICA/B surface expressionSoluble MICA/B (sMICA/sMICB)CD155 (PVR) expressionCD112 (Nectin-2) expressionULBP expression levels

Beyond the preview

Go deeper on Natural killer group 2 member D ligands and DNAX accessory molecule 1 ligands (NKG2DLs and DNAM-1Ls).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural killer group 2 member D ligands and DNAX accessory molecule 1 ligands (NKG2DLs and DNAM-1Ls).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call